| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 8 4004-4010, Copyright © 1995 by American Association of Immunologists
ARTICLES |
R Badolato, JA Johnston, JM Wang, D McVicar, LL Xu, JJ Oppenheim and DJ Kelvin
Biologic Carcinogenesis and Development Program, Program Resources, Inc./Dyncorp, Frederick, MD, USA.
We have previously reported that serum amyloid A (SAA) induces adhesion and chemotaxis of human monocytes and polymorphonuclear neutrophils, in vitro as well as in vivo. Since the mechanism of SAA signaling is unknown, we have investigated the possibility that SAA, like other chemoattractants such as the chemotactic peptide FMLP and chemokines, might induce migration of monocytes by G protein activation. We report here that preincubation of monocytes with pertussis toxin (PTx) inhibited SAA chemotaxis, while incubation with cholera toxin (CTx) did not. Staurosporine and H-7, both inhibitors of protein kinase C (PKC), significantly decreased rSAA-induced chemotaxis of monocytes, suggesting that PKC may be involved in the rSAA signaling pathway. Moreover, rSAA, at concentrations that were effective in chemoattracting monocytes, resulted in transient elevation of cytoplasmic calcium concentration ([Ca2+]i), and incubation of cells with PTx markedly inhibited the mobilization of Ca2+ in response to rSAA. This suggests that both chemotaxis and the rise in [Ca2+]i, are mediated by G proteins of the Gi class. The increase in [Ca2+]i, induced in monocytes by rSAA, was comparable to that elicited by FMLP, and was severalfold greater than that induced by optimal concentrations of chemokine beta-family members such as RANTES, MCAF/MCP-1, and MIP-1 alpha. The chemoattractants FMLP, RANTES, MIP-1 alpha, and MCAF/MCP-1, all failed to desensitize rSAA-induced Ca2+ influx and chemotaxis in monocytes. This suggests that SAA uses a distinct receptor that is coupled to PTx-sensitive G proteins.
This article has been cited by other articles:
|
|
 |
|
  S. Sandri, D. Rodriguez, E. Gomes, H. P. Monteiro, M. Russo, and A. Campa Is serum amyloid A an endogenous TLR4 agonist? J. Leukoc. Biol., May 1, 2008; 83(5): 1174 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bjorkman, J. Karlsson, A. Karlsson, M.-J. Rabiet, F. Boulay, H. Fu, J. Bylund, and C. Dahlgren Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1 J. Leukoc. Biol., February 1, 2008; 83(2): 245 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Christenson, L. Bjorkman, C. Tangemo, and J. Bylund Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1 J. Leukoc. Biol., January 1, 2008; 83(1): 139 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Panes, M. Aceituno, F. Gil, R. Miquel, J. M Pique, A. Salas, and P. McLean Efficacy of an inhibitor of adhesion molecule expression (GI270384X) in the treatment of experimental colitis Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G739 - G748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ohara, Y. Kumon, T. Kobayashi, H. Takeuchi, and T. Sugiura Exocytosis of Neutrophil Formyl Peptide Receptor-Like 1 (fPRL1) Results in Downregulation of Cytoplasmic fPRL1 in Patients with Purulent Dermatitis Clin. Vaccine Immunol., June 1, 2007; 14(6): 678 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. G. Cabana, N. Feng, C. A. Reardon, J. Lukens, N. R. Webb, F. C. de Beer, and G. S. Getz Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro J. Lipid Res., February 1, 2004; 45(2): 317 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Szabo, M. A. Wetzel, N. Zhang, A. D. Steele, D. E. Kaminsky, C. Chen, L.-Y. Liu-Chen, F. Bednar, E. E. Henderson, O. M. Z. Howard, et al. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization J. Leukoc. Biol., December 1, 2003; 74(6): 1074 - 1082. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. C. Grimm, R. Newman, Z. Hassim, N. Cuan, S. J. Connor, Y. Le, J. M. Wang, J. J. Oppenheim, and A. R. Lloyd Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors J. Immunol., November 15, 2003; 171(10): 4990 - 4994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Carnevale and M. K. Cathcart Protein Kinase C {beta} Is Required for Human Monocyte Chemotaxis to MCP-1 J. Biol. Chem., July 3, 2003; 278(28): 25317 - 25322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zhang, D. Hodge, T. J. Rogers, and J. J. Oppenheim Ca2+-independent Protein Kinase Cs Mediate Heterologous Desensitization of Leukocyte Chemokine Receptors by Opioid Receptors J. Biol. Chem., April 4, 2003; 278(15): 12729 - 12736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Thorn and A. S. Whitehead Differential Glucocorticoid Enhancement of the Cytokine-Driven Transcriptional Activation of the Human Acute Phase Serum Amyloid A Genes, SAA1 and SAA2 J. Immunol., July 1, 2002; 169(1): 399 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Hu, Y. Le, W. Gong, N. M. Dunlop, J. L. Gao, P. M. Murphy, and J. M. Wang Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1 J. Leukoc. Biol., July 1, 2001; 70(1): 155 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-Q. Li, M. A. Wetzel, J. A. Mikovits, E. E. Henderson, T. J. Rogers, W. Gong, Y. Le, F. W. Ruscetti, and J. M. Wang The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1 Blood, May 15, 2001; 97(10): 2941 - 2947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-S. Bae, H. Bae, Y. Kim, T. G. Lee, P.-G. Suh, and S. H. Ryu Identification of novel chemoattractant peptides for human leukocytes Blood, May 1, 2001; 97(9): 2854 - 2862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Artl, G. Marsche, S. Lestavel, W. Sattler, and E. Malle Role of Serum Amyloid A During Metabolism of Acute-Phase HDL by Macrophages Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 763 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Le, W. Gong, B. Li, N. M. Dunlop, W. Shen, S. B. Su, R. D. Ye, and J. M. Wang Utilization of Two Seven-Transmembrane, G Protein-Coupled Receptors, Formyl Peptide Receptor-Like 1 and Formyl Peptide Receptor, by the Synthetic Hexapeptide WKYMVm for Human Phagocyte Activation J. Immunol., December 15, 1999; 163(12): 6777 - 6784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Deng, H. Ueda, S. B. Su, W. Gong, N. M. Dunlop, J.-L. Gao, P. M. Murphy, and J. M. Wang A Synthetic Peptide Derived From Human Immunodeficiency Virus Type 1 gp120 Downregulates the Expression and Function of Chemokine Receptors CCR5 and CXCR4 in Monocytes by Activating the 7-Transmembrane G-Protein-Coupled Receptor FPRL1/LXA4R Blood, August 15, 1999; 94(4): 1165 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Su, J.-l. Gao, W.-h. Gong, N. M. Dunlop, P. M. Murphy, J. J. Oppenheim, and J. M. Wang T21/DP107, A Synthetic Leucine Zipper-Like Domain of the HIV-1 Envelope gp41, Attracts and Activates Human Phagocytes by Using G-Protein-Coupled Formyl Peptide Receptors J. Immunol., May 15, 1999; 162(10): 5924 - 5930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Ancsin and R. Kisilevsky The Heparin/Heparan Sulfate-binding Site on Apo-serum Amyloid A. IMPLICATIONS FOR THE THERAPEUTIC INTERVENTION OF AMYLOIDOSIS J. Biol. Chem., March 12, 1999; 274(11): 7172 - 7181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Su, W. Gong, J.-L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang A Seven-transmembrane, G Protein-coupled Receptor, FPRL1, Mediates the Chemotactic Activity of Serum Amyloid A for Human Phagocytic Cells J. Exp. Med., January 18, 1999; 189(2): 395 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.C. Grimm, A. Ben-Baruch, D.D. Taub, O.M.Z. Howard, J.H. Resau, J.M. Wang, H. Ali, R. Richardson, R. Snyderman, and J.J. Oppenheim Opiates Transdeactivate Chemokine Receptors: delta and µ Opiate Receptor-mediated Heterologous Desensitization J. Exp. Med., July 20, 1998; 188(2): 317 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Chertov, H. Ueda, L. L. Xu, K. Tani, W. J. Murphy, J. M. Wang, O.M. Z. Howard, T. J. Sayers, and J. J. Oppenheim Identification of Human Neutrophil-derived Cathepsin G and Azurocidin/CAP37 as Chemoattractants for Mononuclear Cells and Neutrophils J. Exp. Med., August 29, 1997; 186(5): 739 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Villa, C. Meazza, M. Sironi, M. Bianchi, P. Ulrich, G. Botchkina, K.J. Tracey, and P. Ghezzi Protection against lethal polymicrobial sepsis by CNI-1493, an inhibitor of pro-inflammatory cytokine synthesis Innate Immunity, June 1, 1997; 4(3): 197 - 204. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
